Mangoceuticals Inc Revenue per Employee (MGRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Mangoceuticals Inc   (NASDAQ: MGRX)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Mangoceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Mangoceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 14,329, below the company average number of $24,980.
Within the Healthcare sector Employees of 538 other companies have achieved higher revenue per employee. While Mangoceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 3242 to 3588. Mangoceuticals Inc has 22 employees.


What is Sales per Employee Ratio?







MGRX Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -59.1 % -37.91 % -10.34 % -36.83 % 3.03 %
Sales per Employee (TTM) $ 14,329 18,845 20,728 21,223 23,456
MGRX's Total Ranking # 3588 # 3242 # 3135 # 2964 # 2818
Seq. Revenue Change 1.32 % -28.08 % 12.01 % -49.89 % 53.8 %


Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 43
Healthcare Sector # 539
Overall Market # 3588

Revenue per Employee Statistics
High Average Low
$ 39,400 $ 24,980 $ 4,578
(Jun 30 2024)   (Mar 31 2023)



Financial Statements
Mangoceuticals Inc 's Revenue MRQ $ 0 Millions Visit MGRX's Income Statement
Mangoceuticals Inc 's Revenues TTM $ 0 Millions Visit MGRX's aggregate revenue growth
What are MGRX's Sales? Visit MGRX's Sales by Segment




Other Ratios
Mangoceuticals Inc 's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MGRX's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MGRX's Competitors
Revenue per Employee for MGRX's Suppliers
Revenue per Employee for MGRX's Customers

You may also want to know
MGRX's Sales Growth Rates MGRX's Pe Price to earnings ratio MGRX's Receivables Turnover Ratio MGRX's Stock Quote
MGRX's Net Income Growth Rates MGRX's Ps Price to Sales ratio MGRX's Sales per Employee MGRX's Asset Turnover Ratio
MGRX's Net Margin MGRX's Pb Price to Book ratio MGRX's Financial Strength Ratios MGRX's Dividend Payout Ratio
Date modified: 2026-09-02T20:16:47+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Ataibeckley Inc   22,143.56 $ 4.473  Million 202 
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 
Cardiff Oncology Inc   16,387.10 $ 0.508  Million 31 
Mangoceuticals Inc   14,328.50 $ 0.315  Million 22 
Eyepoint Inc   13,028.04 $ 2.788  Million 214 
Absci Corp  11,150.00 $ 1.561  Million 140 
Pluri Inc   11,043.48 $ 1.016  Million 92 
Pulse Biosciences Inc   10,215.52 $ 1.185  Million 116 
Roivant Sciences Ltd   10,042.67 $ 7.532  Million 750 
Skinvisible Inc   10,000.00 $ 0.020  Million
Aclarion Inc   7,615.27 $ 0.084  Million 11 
Lightwave Logic Inc   7,360.32 $ 0.250  Million 34 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.